Poliovirus-Neutralizing Antibody Seroprevalence and Vaccine Habits in a Vaccine-Derived Poliovirus Outbreak Region in the Democratic Republic of Congo in 2018: The Impact on the Global Eradication Initiative
- PMID: 38543880
- PMCID: PMC10975469
- DOI: 10.3390/vaccines12030246
Poliovirus-Neutralizing Antibody Seroprevalence and Vaccine Habits in a Vaccine-Derived Poliovirus Outbreak Region in the Democratic Republic of Congo in 2018: The Impact on the Global Eradication Initiative
Abstract
Despite the successes in wild-type polio eradication, poor vaccine coverage in the DRC has led to the occurrence of circulating vaccine-derived poliovirus outbreaks. This cross-sectional population-based survey provides an update to previous poliovirus-neutralizing antibody seroprevalence studies in the DRC and quantifies risk factors for under-immunization and parental knowledge that guide vaccine decision making. Among the 964 children between 6 and 35 months in our survey, 43.8% (95% CI: 40.6-47.0%), 41.1% (38.0-44.2%), and 38.0% (34.9-41.0%) had protective neutralizing titers to polio types 1, 2, and 3, respectively. We found that 60.7% of parents reported knowing about polio, yet 25.6% reported knowing how it spreads. Our data supported the conclusion that polio outreach efforts were successfully connecting with communities-79.4% of participants had someone come to their home with information about polio, and 88.5% had heard of a polio vaccination campaign. Additionally, the odds of seroreactivity to only serotype 2 were far greater in health zones that had a history of supplementary immunization activities (SIAs) compared to health zones that did not. While SIAs may be reaching under-vaccinated communities as a whole, these results are a continuation of the downward trend of seroprevalence rates in this region.
Keywords: Democratic Republic of the Congo; IPV; OPV; SIAs; cVDPV; nOPV2; poliovirus; serosurvey; vaccine coverage.
Conflict of interest statement
The authors declare no conflict of interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021.Vaccine. 2023 Apr 6;41 Suppl 1(Suppl 1):A35-A47. doi: 10.1016/j.vaccine.2023.02.042. Epub 2023 Mar 11. Vaccine. 2023. PMID: 36907733 Free PMC article.
-
Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria.Vaccine X. 2024 Mar 16;18:100476. doi: 10.1016/j.jvacx.2024.100476. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38617838 Free PMC article.
-
[Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].Bull Soc Pathol Exot. 2015 Oct;108(4):235-41. doi: 10.1007/s13149-015-0447-4. Epub 2015 Aug 18. Bull Soc Pathol Exot. 2015. PMID: 26288132 French.
-
Responding to a cVDPV1 outbreak in Ukraine: Implications, challenges and opportunities.Vaccine. 2017 Aug 24;35(36):4769-4776. doi: 10.1016/j.vaccine.2017.04.036. Epub 2017 May 19. Vaccine. 2017. PMID: 28528761 Free PMC article. Review.
-
Re-emergence of vaccine-derived polio in the demographic Republic of Congo: Causes and consequences.New Microbes New Infect. 2024 Sep 24;62:101489. doi: 10.1016/j.nmni.2024.101489. eCollection 2024 Dec. New Microbes New Infect. 2024. PMID: 39381618 Free PMC article. Review.
References
-
- World Health Organization . Two Out of Three Wild Poliovirus Strains Eradicated. WHO; Geneva, Switzerland: 2019.
-
- CDC Wild Poliovirus Type 1 and Type 3 Importations—15 countries, Africa, 2008–2009. MMWR Morb. Mortal. Wkly. Rep. 2009;58:357–362. - PubMed
-
- Gumede N., Jorba J., Deshpande J., Pallansch M., Yogolelo R., Muyembe-Tamfum J.J., Kew O., Venter M., Burns C.C. Phylogeny of imported and reestablished wild polioviruses in the Democratic Republic of the Congo from 2006 to 2011. J. Infect. Dis. 2014;210((Suppl. 1)):S361–S367. doi: 10.1093/infdis/jiu375. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources